ENGLISH
KOREAN
Company Overview
Business Portfolio
Research & Development
Investment Information
CEO Message
Vision
History
Overseas Corporations
Affiliated Companies
Business Overview
Cord Blood Banking Business
Bio Insurance Business
CHAUM Business(Non-medical)
IT Business
Other Business
CHA Biotech R&D Center
R&D Pipeline
Current Status of Clinical Trials
Patent Grants (Korea/Overseas)
Scientific Publications
IR Presentations
Research & Development
Research & Development
R&D Pipeline
Anti-cancer Immunotherapy (CB-IC-01 : Autologous Killer Cell)
Next generation NK cell therapy, "AKC Immunotherapy"
Proprietary high-level NK cell cultivation technique
Found anti-cancer efficacy in various solid cancers
Currently IITs for Recurrent Glioblastoma and Recurrent Ovarian
Cancer ongoing
Peripheral Blood Mononuclear Cell Isolation and Final Product Cryopreservation
CEO Message
Vision
History
Overseas Corporations
Affiliated Companies
Business Overview
Cord Blood Banking Business
Bio Insurance Business
CHAUM Business(Non-medical)
IT Business
Other Business
CHA Biotech R&D Center
R&D Pipeline
Current Status of Clinical Trials
Patent Grants (Korea/Overseas)
Scientific Publications
IR Presentations
CHA GROUP SITE
CHA Biomedical Group
CHA Cares
CHA-Meditech
CHA Bio F&C
Seoul CRO
Solidus Investment
CHA Vaccine Institute
CMG Pharmaceutical
CHA Healthcare
Cord Blood Bank iCord
Stem Cell Bank Bio Insurance
Paramedic
Chaum
Chaum CHA Biotech